Skip to content

BIOMEDIM: what changed

What changed

BIOMEDIM

BE 0832.829.231
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€64,037
2024 · €65,097-€1,061
Equity
€372,895
2024 · €309,692+€63,204
Cash
€67,946
2024 · €18,724+€49,221
Balance sheet total
€430,148
2024 · €339,016+€91,132

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€158,458

    up €158,458 (+205%), from €77,462 to €235,920

    of which Trade receivables: +€156,100

  • Current investments -€150,000

    no longer reported in 2025 (was €150,000)

  • Cash +€49,221

    up €49,221 (+263%), from €18,724 to €67,946

    mainly Current investments (+€150,000) and Net result for the year (+€64,037)

  • Stocks and contracts +€34,398

    up €34,398 (+38.5%), from €89,371 to €123,769

Equity and liabilities
  • Reserves +€63,000

    up €63,000 (+25.2%), from €249,800 to €312,800

  • Provisions +€17,000

    new in 2025: €17,000

  • Other debts +€7,105

    up €7,105 (+36.6%), from €19,407 to €26,512

Income statement
  • Gross operating margin +€18,717

    up €18,717 (+20.5%), from €91,344 to €110,061

  • Provisions +€17,000

    new in 2025: €17,000

  • Financial income -€2,836

    down €2,836 (-90.6%), from €3,129 to €293

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €65,097
Gross operating margin +€18,717
Depreciation -€9
Provisions -€17,000
Other operating charges -€530
Financial income -€2,836
Financial charges -€213
Taxes +€810
Result 2025 €64,037
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€99,946
Investment +€150,000
Financing -€833
Cash 2024 €18,724
Net result for the year +€64,037
Depreciation +€969
Stocks and contracts -€34,398
Receivables within one year -€158,458
Deferred charges and accrued income -€23
Provisions +€17,000
Trade debts +€1,006
Tax, wage and social debts +€2,817
Other debts +€7,105
Current investments +€150,000
Contributions, distributions and other -€833
Cash 2025 €67,946
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €339,016 €430,148 +€91,132 +26.9%
Fixed assets 21/28 €2,819 €1,850 -€969 -34.4%
Tangible fixed assets 22/27 €2,474 €1,505 -€969 -39.2%
Furniture and vehicles 24 €686 €348 -€338 -49.3%
Other tangible fixed assets 26 €1,788 €1,157 -€631 -35.3%
Financial fixed assets 28 €345 €345 = 0.0%
Current assets 29/58 €336,198 €428,298 +€92,100 +27.4%
Stocks and contracts in progress 3 €89,371 €123,769 +€34,398 +38.5%
Stocks 30/36 €89,371 €123,769 +€34,398 +38.5%
Amounts receivable within one year 40/41 €77,462 €235,920 +€158,458 +205%
Trade receivables 40 €77,462 €233,562 +€156,100 +202%
Other amounts receivable 41 - €2,358 +€2,358
Current investments 50/53 €150,000 - -€150,000
Cash at bank and in hand 54/58 €18,724 €67,946 +€49,221 +263%
Deferred charges and accrued income 490/1 €640 €663 +€23 +3.5%
Total equity and liabilities 10/49 €339,016 €430,148 +€91,132 +26.9%
Equity 10/15 €309,692 €372,895 +€63,204 +20.4%
Contributions 10/11 €50,000 €50,000 = 0.0%
Reserves 13 €249,800 €312,800 +€63,000 +25.2%
Distributable reserves 133 €249,800 €312,800 +€63,000 +25.2%
Profit (loss) carried forward 14 €9,892 €10,095 +€204 +2.1%
Provisions and deferred taxes 16 - €17,000 +€17,000
Provisions for liabilities and charges 160/5 - €17,000 +€17,000
Other liabilities and charges 164/5 - €17,000 +€17,000
Amounts payable 17/49 €29,325 €40,253 +€10,928 +37.3%
Amounts payable within one year 42/48 €29,325 €40,253 +€10,928 +37.3%
Trade debts 44 €993 €1,999 +€1,006 +101%
Suppliers 440/4 €993 €1,999 +€1,006 +101%
Taxes, remuneration and social security 45 €8,924 €11,742 +€2,817 +31.6%
Taxes 450/3 €8,924 €11,742 +€2,817 +31.6%
Other amounts payable 47/48 €19,407 €26,512 +€7,105 +36.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €960 €969 +€9 +1.0%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 - €17,000 +€17,000
Other operating charges 640/8 €1,493 €2,023 +€530 +35.5%
Gross operating margin 9900 €91,344 €110,061 +€18,717 +20.5%
Operating profit (loss) 9901 €88,891 €90,069 +€1,178 +1.3%
Financial income 75/76B €3,129 €293 -€2,836 -90.6%
Recurring financial income 75 €3,129 €293 -€2,836 -90.6%
Financial charges 65/66B €1,384 €1,597 +€213 +15.4%
Recurring financial charges 65 €1,384 €1,597 +€213 +15.4%
Profit (loss) for the period before taxes 9903 €90,636 €88,765 -€1,871 -2.1%
Income taxes 67/77 €25,539 €24,729 -€810 -3.2%
Profit (loss) for the period 9904 €65,097 €64,037 -€1,061 -1.6%
Profit (loss) for the period to be appropriated 9905 €65,097 €64,037 -€1,061 -1.6%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.